NORTHERN TRUST CORP - ALLOGENE THERAPEUTICS INC ownership

ALLOGENE THERAPEUTICS INC's ticker is ALLO and the CUSIP is 019770106. A total of 176 filers reported holding ALLOGENE THERAPEUTICS INC in Q2 2020. The put-call ratio across all filers is 0.55 and the average weighting 0.7%.

Quarter-by-quarter ownership
NORTHERN TRUST CORP ownership history of ALLOGENE THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$2,727,871
-36.4%
860,527
-0.2%
0.00%0.0%
Q2 2023$4,286,656
+8.6%
862,506
+7.9%
0.00%0.0%
Q1 2023$3,947,915
-24.4%
799,173
-3.8%
0.00%0.0%
Q4 2022$5,223,242
-58.5%
830,404
-28.8%
0.00%
-66.7%
Q3 2022$12,588,000
+46.8%
1,165,610
+54.9%
0.00%
+50.0%
Q2 2022$8,576,000
+34.7%
752,309
+7.6%
0.00%
+100.0%
Q1 2022$6,368,000
-41.1%
699,080
-3.5%
0.00%
-50.0%
Q4 2021$10,813,000
-41.0%
724,717
+1.6%
0.00%
-33.3%
Q3 2021$18,336,000
-4.4%
713,502
-2.9%
0.00%0.0%
Q2 2021$19,172,000
-16.2%
735,094
+13.4%
0.00%
-25.0%
Q1 2021$22,890,000
+35.6%
648,464
-3.0%
0.00%
+33.3%
Q4 2020$16,875,000
-34.3%
668,607
-1.9%
0.00%
-50.0%
Q3 2020$25,703,000
-10.8%
681,587
+1.3%
0.01%
-14.3%
Q2 2020$28,803,000
+185.8%
672,618
+29.7%
0.01%
+133.3%
Q1 2020$10,079,000
-24.2%
518,494
+1.3%
0.00%0.0%
Q4 2019$13,302,000
-7.6%
512,015
-3.0%
0.00%0.0%
Q3 2019$14,390,000
+72.3%
527,980
+69.8%
0.00%
+50.0%
Q2 2019$8,351,000
-0.4%
311,021
+7.2%
0.00%0.0%
Q1 2019$8,385,000
+8.8%
290,050
+1.3%
0.00%0.0%
Q4 2018$7,709,000286,2400.00%
Other shareholders
ALLOGENE THERAPEUTICS INC shareholders Q2 2020
NameSharesValueWeighting ↓
Vida Ventures Advisors, LLC 1,798,163$45,386,0009.32%
TPG Group Holdings (SBS) Advisors, Inc. 18,716,306$472,400,0005.23%
Wildcat Capital Management, LLC 1,515,524$38,252,0004.81%
REGENTS OF THE UNIVERSITY OF CALIFORNIA 900,143$22,720,0003.28%
Coastal Bridge Advisors, LLC 385,824$9,738,0001.93%
Casdin Capital, LLC 945,000$23,852,0000.71%
DSAM Partners (London) Ltd 208,798$5,270,0000.62%
BAINCO INTERNATIONAL INVESTORS 152,839$3,858,0000.44%
Pier Capital, LLC 152,071$3,838,0000.41%
Woodline Partners LP 567,539$14,325,0000.38%
View complete list of ALLOGENE THERAPEUTICS INC shareholders